No abstract

No abstract

The results of this study demonstrate the therapeutic potential of this novel polyherbal formulation for the management and treatment of SDAT.

Purpose: The fruits of Limonia acidissima Linn are used traditionally in India for the treatment of tumours, asthma, wounds, cardiac debility and hepatitis. The purpose of the present study was to evaluate the wound healing activity of the methanol extract of its fruit pulp (MELA) in incision, excision and dead-space wound models. Methods: Albino rats of either sex were divided into four groups, viz, wounded control, wounded rats administered standard drug, nitrofurazone (2 %), and wounded rats administered MELA 200 and 400 mg/kg, respectively. In incision wound model, wound breaking strength and epithelization period were evaluated, while in excision wound model, wound contraction was studied. In dead-space wound model, granulation tissue dry weight, hydroxyproline levels in dry granulation tissue, as well as superoxide dismutase (SOD) and catalase levels in wet granulation tissue were estimated. Granulation tissue was subjected to histopathological examination in order to determine whether there was healing by formation of collagen in the wound tissue in extract-treated animals. Results: Increased wound breaking strength, decreased epithelization period, increased wound contraction, increased granulation tissue weight and hydroxyproline concentration were observed in the various groups, compared with the control group. Also, increased activity of anti-oxidant enzymes, i.e., higher SOD and catalase levels, were seen in extract-treated groups when compared to controls. Wound healing activity was statistically significant (p < 0.001) in animals treated with 400 mg/kg of the extract. Conclusion: The methanol extract of L. acidissima possesses significant dose-dependant wound healing and anti-oxidant activities; this supports traditional claims for the plant as a wound healer.

No abstract

Rosmarinic acid (RA), a polyphenol, is known to improve hepatic insulin sensitivity in experimental type 2 diabetes. However, its effect on skeletal muscle insulin resistance is meagerly understood. The present study was aimed to investigate the up- and downstream mediators of the molecular targets of RA in attenuating insulin resistance in the skeletal muscle both in vivo and in vitro. We found that supplementation of RA increased the expression of key genes involved in the mitochondrial biogenesis like PGC-1α, SIRT-1, and TFAM via activation of AMPK in the skeletal muscle of insulin resistant rats as well as in L6 myotubes. Further, RA treatment increased the glucose uptake and decreased the phosphorylation of serine IRS-1 while increasing the translocation of GLUT 4. Together, our findings evidenced that RA treatment significantly inhibit insulin resistance in skeletal muscle cells by enhancing mitochondrial biogenesis. J. Cell. Biochem. 118: 1839-1848, 2017. © 2017 Wiley Periodicals, Inc.

No abstract

Cytochrome P450 (CYP450) inhibition by the bioactive molecules of dietary supplements or herbal products leading to greater potential for toxicity of co-administered drugs. The present study was aimed to compare the inhibitory potential of selected common dietary bioactive molecules (Gallic acid, Ellagic acid, β-Sitosterol, Stigmasterol, Quercetin and Rutin) on CYP3A4 and CYP2D6 to assess safety through its inhibitory potency and to predict interaction potential with co-administered drugs. CYP450-CO complex assay was carried out for all the selected dietary bioactive molecules in isolated rat microsomes. CYP450 concentration of the rat liver microsome was found to be 0.474 nmol/mg protein, quercetin in DMSO has shown maximum inhibition on CYP450 (51.02±1.24 %) but less when compared with positive control (79.02±1.61 %). In high throughput fluorometric assay, IC 50 value of quercetin (49.08±1.02-54.36± 0.85 μg/ml) and gallic acid (78.46±1.32-83.84±1.06 μg/ml) was lower than other bioactive compounds on CYP3A4 and CYP2D6 respectively but it was higher than positive controls (06.28±1.76-07.74±1.32 μg/ml). In comparison of in vitro inhibitory potential on CYP3A4 and CYP2D6, consumption of food or herbal or dietary supplements containing quercetin and gallic acid without any limitation should be carefully considered when narrow therapeutic drugs are administered together.